A trial of a specialist pharmacist review of medications for people moving to residential care for the first time
Not Applicable
- Conditions
- PolypharmacyFrailty
- Registration Number
- ACTRN12618000580279
- Lead Sponsor
- Claire Heppenstall
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link polypharmacy reduction to frailty outcomes in ACTRN12618000580279?
How does specialist pharmacist review compare to standard care in preventing adverse drug events in residential care?
Which biomarkers predict successful medication optimization in frail elderly patients entering residential care?
What adverse event management strategies are critical for pharmacist-led de-prescribing in polypharmacy?
Are there combination approaches with pharmacist review and tools like Beers criteria to improve geriatric medication safety?